Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally. It is also involved in consumer healthcare business; manufacturing, sale, analytical testing, and pharmaceutical engineering of medicinal drugs and investigational drugs; contracted monitoring of epidemiological components in sewage; promotion of implementation in social infrastructure; and business related to providing data and information; develops and sells foothold; and research and development of mucosal vaccines. In addition, the company provides contract support services for experimental research; contract testing of agricultural production materials; solutions for education and healthcare, system development, human resource development, and training business; marketing support services; and IT services for medical and healthcare-related issues. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. The company was founded in 1878 and is headquartered in Kita, Japan.
Frequently asked questions
What sector does Shionogi & Co. Ltd (SGIOF) operate in?
Shionogi & Co. Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Shionogi & Co. Ltd (SGIOF) current stock price?
As of the latest data, Shionogi & Co. Ltd stock price is $18.00, with a previous close of $18.00.
What is Shionogi & Co. Ltd (SGIOF) current market capitalization?
Shionogi & Co. Ltd market cap is approximately 15.32 billion.
What is Shionogi & Co. Ltd (SGIOF) Earnings Per Share (EPS)?
The trailing EPS is $1.60.
What is Shionogi & Co. Ltd (SGIOF) Price-to-Earnings (P/E) ratio?
Shionogi & Co. Ltd current P/E ratio is 11.25.
What is Shionogi & Co. Ltd (SGIOF) EBITDA?
Shionogi & Co. Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 60.19 billion.
Does Shionogi & Co. Ltd (SGIOF) pay dividends?
Yes. Shionogi & Co. Ltd pays semiannual dividends with an annualized yield of 3.93% and an estimated annual payout of $0.71 per share.
When is the next ex-dividend date for Shionogi & Co. Ltd (SGIOF)?
The next ex-dividend date is scheduled for March 31, 2027.
How did Shionogi & Co. Ltd (SGIOF) perform in its most recent earnings report?
In the last report (June 30, 2026), Shionogi & Co. Ltd posted an EPS surprise of -98.31% and a revenue surprise of 2.18%.
What is Shionogi & Co. Ltd (SGIOF) beta (volatility) score?
Shionogi & Co. Ltd has a beta of 0.065, indicating lower volatility than the overall market.
